Patel Manish M, Tate Jacqueline E, Selvarangan Rangaraj, Daskalaki Irini, Jackson Mary Anne, Curns Aaron T, Coffin Susan, Watson Barbara, Hodinka Richard, Glass Roger I, Parashar Umesh D
Centers for Disease Control and Prevention, National Center for Immunizations and Respiratory Diseases, Atlanta, GA 30329, USA.
Pediatr Infect Dis J. 2007 Oct;26(10):914-9. doi: 10.1097/INF.0b013e31812e52fd.
The recent implementation of a rotavirus vaccination program in the United States makes it imperative to assess the impact of immunization on the incidence of severe rotavirus disease leading to hospitalization. Active surveillance for laboratory-confirmed rotavirus hospitalizations is the ideal approach for surveillance, but requires substantial resources to implement. We examined laboratory and hospital discharge data for 2 tertiary care pediatric hospitals to assess the utility of routine laboratory testing data for surveillance of rotavirus gastroenteritis and to estimate rotavirus disease burden.
We obtained all discharge records of hospitalizations for acute gastroenteritis among children <5 years of age at Children's Mercy Hospital (CMH), Kansas City, from July 2000 to June 2005 and at Children's Hospital of Philadelphia (CHOP) from July 2004 to June 2006. We linked these discharge records to laboratory results of rotavirus testing to evaluate epidemiologic differences in children who were tested and not tested for rotavirus and to estimate overall rotavirus burden by extrapolating clinical testing results to the untested group.
At CMH, of the 3702 children with acute gastroenteritis, 69% (n = 2552) were discharged during the winter (January through May) months, when rotavirus is most common. Similarly, at CHOP, 62% (n = 779) of the 1261 gastroenteritis discharges occurred during the winter months. During these months, 47% (n = 1197 of 2552) of the discharges at CMH and 56% (n = 438 of 779) of the discharges at CHOP were tested for rotavirus and of those tested, 71% (n = 853 of 1197) and 55% (n = 242 of 438) were positive, respectively. At both hospitals, children with and without rotavirus testing had similar gender and race/ethnicity, but the rate of testing differed by age at CHOP and by month of admission at CMH. After adjusting for these differences, we estimate that 56%-70% of winter and 34%-48% of year-round gastroenteritis in children <5 years can be attributable to rotavirus. Overall, 3%-5% of all hospitalizations in children <5 years of age were caused by rotavirus.
Sentinel hospitals where a large proportion of children hospitalized for gastroenteritis are routinely tested for rotavirus could provide a useful and cost-efficient platform to complement ongoing active surveillance efforts to evaluate the impact of rotavirus vaccination. The data reaffirm the substantial burden of rotavirus hospitalizations in US children and the potential health benefits of vaccination.
美国近期实施了轮状病毒疫苗接种计划,因此必须评估免疫接种对导致住院的严重轮状病毒疾病发病率的影响。对实验室确诊的轮状病毒住院病例进行主动监测是理想的监测方法,但实施起来需要大量资源。我们检查了两家三级护理儿童医院的实验室和出院数据,以评估常规实验室检测数据在监测轮状病毒胃肠炎方面的效用,并估计轮状病毒疾病负担。
我们获取了堪萨斯城儿童医院(CMH)2000年7月至2005年6月以及费城儿童医院(CHOP)2004年7月至2006年6月期间5岁以下儿童急性胃肠炎住院的所有出院记录。我们将这些出院记录与轮状病毒检测的实验室结果相关联,以评估进行轮状病毒检测和未进行检测的儿童的流行病学差异,并通过将临床检测结果外推至未检测组来估计总体轮状病毒负担。
在CMH,3702例急性胃肠炎患儿中,69%(n = 2552)在轮状病毒最常见的冬季(1月至5月)出院。同样,在CHOP,1261例胃肠炎出院病例中有62%(n = 779)发生在冬季。在这些月份,CMH的出院病例中有47%(2552例中的1197例)进行了轮状病毒检测,CHOP的出院病例中有56%(779例中的438例)进行了检测,其中检测呈阳性的分别为71%(1197例中的853例)和55%(438例中的242例)。在两家医院,进行和未进行轮状病毒检测的儿童在性别和种族/民族方面相似,但CHOP的检测率因年龄而异,CMH的检测率因入院月份而异。在调整这些差异后,我们估计5岁以下儿童冬季胃肠炎的56% - 70%以及全年胃肠炎的34% - 48%可归因于轮状病毒。总体而言,5岁以下儿童所有住院病例中有3% - 5%是由轮状病毒引起的。
在因胃肠炎住院的儿童中很大一部分会常规进行轮状病毒检测的定点医院,可以提供一个有用且具有成本效益的平台,以补充正在进行的主动监测工作,从而评估轮状病毒疫苗接种的影响。这些数据再次证实了美国儿童轮状病毒住院的巨大负担以及疫苗接种对健康的潜在益处。